Ampio Pharmaceuticals Inc (AMPE)
0.0022
0.00 (0.00%)
USD |
OTCM |
Sep 27, 16:00
Ampio Pharmaceuticals Research and Development Expense (TTM): 2.439M for Dec. 31, 2023
Research and Development Expense (TTM) Chart
Historical Research and Development Expense (TTM) Data
| Date | Value |
|---|---|
| December 31, 2023 | 2.439M |
| September 30, 2023 | 1.936M |
| June 30, 2023 | 4.354M |
| March 31, 2023 | 5.753M |
| December 31, 2022 | 8.916M |
| September 30, 2022 | 12.91M |
| June 30, 2022 | 12.76M |
| March 31, 2022 | 13.29M |
| December 31, 2021 | 11.90M |
| September 30, 2021 | 9.308M |
| June 30, 2021 | 8.369M |
| March 31, 2021 | 7.214M |
| December 31, 2020 | 9.172M |
| September 30, 2020 | 12.52M |
| June 30, 2020 | 14.29M |
| March 31, 2020 | 15.31M |
| December 31, 2019 | 12.62M |
| September 30, 2019 | 8.614M |
| June 30, 2019 | 6.370M |
| March 31, 2019 | 6.348M |
| December 31, 2018 | 6.829M |
| September 30, 2018 | 8.781M |
| June 30, 2018 | 9.590M |
| March 31, 2018 | 10.82M |
| December 31, 2017 | 10.42M |
| Date | Value |
|---|---|
| September 30, 2017 | 8.624M |
| June 30, 2017 | 8.420M |
| March 31, 2017 | 7.875M |
| December 31, 2016 | 10.55M |
| September 30, 2016 | 13.33M |
| June 30, 2016 | 15.19M |
| March 31, 2016 | 15.50M |
| December 31, 2015 | 15.11M |
| September 30, 2015 | 13.47M |
| June 30, 2015 | 16.04M |
| March 31, 2015 | 18.56M |
| December 31, 2014 | 22.47M |
| September 30, 2014 | 24.80M |
| June 30, 2014 | 23.00M |
| March 31, 2014 | 22.10M |
| December 31, 2013 | 17.06M |
| September 30, 2013 | 12.83M |
| June 30, 2013 | 10.54M |
| March 31, 2013 | 7.358M |
| December 31, 2012 | 6.044M |
| September 30, 2012 | 8.762M |
| June 30, 2012 | 8.031M |
| March 31, 2012 | 7.488M |
| December 31, 2011 | 6.648M |
| September 30, 2011 | 3.602M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
1.936M
Minimum
Sep 2023
15.31M
Maximum
Mar 2020
9.538M
Average
9.24M
Median
Research and Development Expense (TTM) Benchmarks
| Athersys Inc | 29.98M |
| FluoroPharma Medical Inc | 0.5551M |
| Evolutionary Genomics Inc | 0.4175M |
| MetaStat Inc | 1.451M |
| Xeno Transplants Corp | -- |